January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The automated and closed cell therapy processing systems market size is calculated at $1.74 bn in 2025 is to hit $8.86 bn by 2034. The automated and closed cell therapy market sees key advancements: Cellular Origins partnered with Fresenius Kabi (Oct 2024) for robotic manufacturing; Multiply Labs collaborated with Stanford Medicine (Apr 2024) on au...
April 21, 2026
The food allergy treatment market size is calculated at $7.47 bn in 2025 is to hit $15.32 bn by 2034. In 2024, notable advancements in food allergy treatment include Mitsubishi Gas Chemical's partnership with Alerje to enhance global allergy care, the U.S. FDA's approval of Xolair for severe allergies, and Inimmune's collaboration with Intrommune t...
April 21, 2026
The organ transplant immunosuppressant drugs market size is calculated at $5.81 bn in 2025 is to hit $8.82 bn by 2034. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. Duke Children’s Hospital launched a trial on new anti-rejection medications in children. Astel...
April 21, 2026
The cholera vaccines market size is calculated at $103.99 mn in 2025 is to hit $246 mn by 2034. In early 2025, Nakonde, Zambia, launched a cholera vaccination campaign targeting 191,153 people. In October 2024, India’s ICMR and NIRBD began a pilot project to vaccinate 50,000 individuals with Euvichol-Plus. In March 2024, IVI initiated a tech ...
April 21, 2026
The enzyme replacement therapy market size is calculated at $11.34 bn in 2025 is to hit $24.71 bn by 2034. In January 2025, Denali Therapeutics received FDA Breakthrough Therapy Designation for DNL310 (tividenofusp alfa) for Hunter syndrome. In July 2024, GC Biopharma’s GC1130A got fast-track status for Sanfilippo syndrome type A. In December...
April 21, 2026
The stroke rehabilitation market size is calculated at $317.02 mn in 2025 is to hit $817.06 mn by 2034. In 2024, North America led the market, while Asia-Pacific is projected to grow fastest during the forecast period. The ischemic stroke segment dominated the stroke rehabilitation market, but hemorrhagic stroke will see notable growth. Hospitals l...
April 21, 2026
The allergy immunotherapy market size is calculated at $2.12 bn in 2025 is to hit $4.50 bn by 2034. In 2024, Europe led the allergy immunotherapy market share of 68%, with subcutaneous immunotherapy dominating treatment types. The tablets segment held the largest market share, while the drops segment is expected to grow significantly. The allergy r...
April 21, 2026
According to the insight, the medical rehabilitation services market size is calculated at $287.28 bn in 2025 is to hit $492.4 bn by 2034. In 2024, North America held 43% of the medical rehabilitation market. Physical therapy led, while cognitive therapy is expected to grow fastest. Outpatient settings were dominant, with significant growth for inp...
April 21, 2026
According to market projections, the inhalation anesthesia sector is expected to grow from USD 1.64 billion in 2025 to USD 2.94 billion by 2034. In 2024, North America led the inhalation anesthesia market (53% share), with Asia-Pacific poised for rapid growth. Sevoflurane dominated by drug, while desflurane shows promising growth. Maintenance appli...
April 21, 2026
According to market projections, the radiation therapy sector is expected to grow from USD 7.86 billion in 2025 to USD 12.93 billion by 2034. In 2024, key investments boosted cancer treatment innovation: £2.94M to RadNet Leeds for radiation research, £70M for new radiation equipment after lobbying by Radiation UK, and £1.5B for su...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com